1. Home
  2. KFRC vs BCYC Comparison

KFRC vs BCYC Comparison

Compare KFRC & BCYC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KFRC
  • BCYC
  • Stock Information
  • Founded
  • KFRC 1962
  • BCYC 2009
  • Country
  • KFRC United States
  • BCYC United Kingdom
  • Employees
  • KFRC N/A
  • BCYC N/A
  • Industry
  • KFRC Professional Services
  • BCYC Biotechnology: Pharmaceutical Preparations
  • Sector
  • KFRC Consumer Discretionary
  • BCYC Health Care
  • Exchange
  • KFRC Nasdaq
  • BCYC Nasdaq
  • Market Cap
  • KFRC 592.8M
  • BCYC 492.1M
  • IPO Year
  • KFRC 1995
  • BCYC 2019
  • Fundamental
  • Price
  • KFRC $30.37
  • BCYC $8.23
  • Analyst Decision
  • KFRC Buy
  • BCYC Buy
  • Analyst Count
  • KFRC 3
  • BCYC 11
  • Target Price
  • KFRC $52.33
  • BCYC $22.91
  • AVG Volume (30 Days)
  • KFRC 254.1K
  • BCYC 292.7K
  • Earning Date
  • KFRC 10-27-2025
  • BCYC 10-30-2025
  • Dividend Yield
  • KFRC 5.14%
  • BCYC N/A
  • EPS Growth
  • KFRC N/A
  • BCYC N/A
  • EPS
  • KFRC 2.39
  • BCYC N/A
  • Revenue
  • KFRC $1,361,445,000.00
  • BCYC $19,281,000.00
  • Revenue This Year
  • KFRC N/A
  • BCYC N/A
  • Revenue Next Year
  • KFRC $0.75
  • BCYC N/A
  • P/E Ratio
  • KFRC $12.71
  • BCYC N/A
  • Revenue Growth
  • KFRC N/A
  • BCYC N/A
  • 52 Week Low
  • KFRC $29.33
  • BCYC $6.10
  • 52 Week High
  • KFRC $62.80
  • BCYC $28.67
  • Technical
  • Relative Strength Index (RSI)
  • KFRC 45.43
  • BCYC 64.05
  • Support Level
  • KFRC $29.48
  • BCYC $7.40
  • Resistance Level
  • KFRC $30.35
  • BCYC $8.69
  • Average True Range (ATR)
  • KFRC 0.89
  • BCYC 0.37
  • MACD
  • KFRC 0.19
  • BCYC 0.15
  • Stochastic Oscillator
  • KFRC 43.41
  • BCYC 75.53

About KFRC Kforce Inc.

Kforce Inc is a solutions firm specializing in technology, finance and accounting, and other professional staffing services. The company operates two business segments: 1) In technology segment it provides talent solutions with candidates skilled in areas including systems/applications architecture and development, data management and analytics, business and artificial intelligence, machine learning, project and program management, and network architecture and security. 2) In FA segment company offers consultants in traditional finance and accounting roles such as finance, planning and analysis; business intelligence analysis; general accounting; transactional accounting business and cost analysis; and taxation and treasury. The majority of revenue is earned through the technology segment.

About BCYC Bicycle Therapeutics plc

Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops that stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical needs. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC. The company has two segments: the United Kingdom and the United States. It derives maximum revenue from United States.

Share on Social Networks: